Faculty Opinions recommendation of Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans.

Author(s):  
Kouichi Morita
Viruses ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1651
Author(s):  
Janusz T. Pawęska ◽  
Petrus Jansen van Vuren ◽  
Veerle Msimang ◽  
Modu Moustapha Lô ◽  
Yaya Thiongane ◽  
...  

Diagnostic performance of an indirect enzyme-linked immunosorbent assay (I-ELISA) based on a recombinant nucleocapsid protein (rNP) of the Rift Valley fever virus (RVFV) was validated for the detection of the IgG antibody in sheep (n = 3367), goat (n = 2632), and cattle (n = 3819) sera. Validation data sets were dichotomized according to the results of a virus neutralization test in sera obtained from RVF-endemic (Burkina Faso, Democratic Republic of Congo, Mozambique, Senegal, Uganda, and Yemen) and RVF-free countries (France, Poland, and the USA). Cut-off values were defined using the two-graph receiver operating characteristic analysis. Estimates of the diagnostic specificity of the RVFV rNP I-ELISA in animals from RVF-endemic countries ranged from 98.6% (cattle) to 99.5% (sheep) while in those originating from RVF-free countries, they ranged from 97.7% (sheep) to 98.1% (goats). Estimates of the diagnostic sensitivity in ruminants from RVF-endemic countries ranged from 90.7% (cattle) to 100% (goats). The results of this large-scale international validation study demonstrate the high diagnostic accuracy of the RVFV rNP I-ELISA. Standard incubation and inactivation procedures evaluated did not have an adverse effect on the detectable levels of the anti-RVFV IgG in ruminant sera and thus, together with recombinant antigen-based I-ELISA, provide a simple, safe, and robust diagnostic platform that can be automated and carried out outside expensive bio-containment facilities. These advantages are particularly important for less-resourced countries where there is a need to accelerate and improve RVF surveillance and research on epidemiology as well as to advance disease control measures.


2012 ◽  
Vol 93 (3) ◽  
pp. 330-339 ◽  
Author(s):  
Mary Ellenbecker ◽  
Leila Sears ◽  
Ping Li ◽  
Jean-Marc Lanchy ◽  
J. Stephen Lodmell

2007 ◽  
Vol 146 (1-2) ◽  
pp. 327-334 ◽  
Author(s):  
A. Sobarzo ◽  
J.T. Paweska ◽  
S. Herrmann ◽  
T. Amir ◽  
R.S. Marks ◽  
...  

2013 ◽  
Vol 159 (3) ◽  
pp. 535-546 ◽  
Author(s):  
Susanne Jäckel ◽  
Martin Eiden ◽  
Malte Dauber ◽  
Anne Balkema-Buschmann ◽  
Alejandro Brun ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (3) ◽  
pp. e59210 ◽  
Author(s):  
Weidong Xu ◽  
Douglas M. Watts ◽  
Margaret C. Costanzo ◽  
Xiaolei Tang ◽  
Leon A. Venegas ◽  
...  

2013 ◽  
Vol 95 (2) ◽  
pp. 725-730 ◽  
Author(s):  
S. Jäckel ◽  
M. Eiden ◽  
A. Balkema-Buschmann ◽  
M. Ziller ◽  
P. Jansen van Vuren ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document